Interface - A New Series from <i>NEJM Evidence</i>.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38319844.
- Also identified by DOI 10.1056/EVIDe2200173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interface - A New Series from <i>NEJM Evidence</i> A major motivation for the launch of <i>NEJM Evidence</i> was a belief that understanding the nuances of study design and execution is key to assessing how the results of a study can, or cannot, influence clinical practice. A corollary is that maximizing clinical utility should be the major focus of study design. It is now widely appreciated that these goals are not optimally achieved solely by relying on binary interpretation of P values in traditional randomized controlled trials.<sup>1</sup>.